Australia's Argenica Therapeutics scales record high on U.S. patent grant

Argenica Therapeutics

09/12/2021 24:56

** Shares of biotechnology co Argenica Therapeutics  AGN.AX 
climb as much as 11.6% to a record A$0.745
    ** Co says the U.S. Patent and Trademark Office issued a
Notice of Allowance for co's drug candidate ARG-007, which aims
to reduce brain cell death  urn:newsml:reuters.com:*:nASXc548MS 
    ** Patent covers use of drug as therapeutic compound in the
events of stroke, traumatic brain injury and hypoxic ischaemic
encephalopathy - a type of brain dysfunction
    ** Stock eyes best day since Nov. 30; up 157% since June 11
debut, as of last close

 (Reporting by Harshita Swaminathan in Bengaluru)
 ((Harshita.Swaminathan@thomsonreuters.com))